|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 05744858.1 (espacenet) (Federated) (European Patent Register), 20050518 | | Patent/reg. no. and date | DK/EP 1753431, 20090819 | | Publication date | 20070221 | | Priority no. and date | GB 0411378, 20040521 | | EP pub. no. and date |
EP 1753431 20070221 | | Effective date | | | Applicant/owner | Genzyme Corporation, 500 Kendall Street
Cambridge MA 02142, US | | Applicant ref. no. | AST 101466-1X | | Inventor | STOTT, Paul. William,
c/o AstraZeneca, Charter Way, Macclesfield
Cheshire SK10 2NA, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 47/02 (2006.01) , A61K 47/38 (2006.01) | | Title | Farmaceutisk sammensætning omfattende ZD6474 | | Int. application no. | GB2005001931 | | Int. publication no. | WO2005112934 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
